Skip to main content

Table 3 The cross-sectional analysis for outcomes in lung transplant recipients with and without bronchiectasis

From: Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis

 

All patients n = 124

Bronchiectasis n = 13

Non-bronchiectasis n = 111

p value

Median time of follow-up, months (IQR)

59 (21–99)

46 (15–89)

60 (21–100)

0.504

Death, n (%)

35 (28.2%)

5 (38.5%)

30 (27.0%)

0.515

Cause of death

 Infection

10 (26.6%)

3 (60.0%)

7 (23.3%)

0.642

 CLAD

9 (25.7%)

2 (40.0%)

7 (23.3%)

 

 Primary graft dysfunction

6 (17.1%)

0 (0.0%)

6 (20.0%)

 

 Cardiovascular complications

3 (8.6%)

0 (0.0%)

3 (10.0%)

 

 Gastrointestinal complications

2 (5.7%)

0 (0.0%)

2 (6.7%)

 

 Malignancy

2 (5.7%)

0 (0.0%)

2 (6.7%)

 

 Technical complications

1 (2.9%)

0 (0.0%)

1 (3.3%)

 

 Other

2 (5.7%)

0 (0.0%)

2 (6.7%)

 

Median time to death, months (IQR)

15 (1–58)

25 (3–85)

14 (1–58)

0.775

CLAD, n (%)

35 (28.2%)

4 (30.8%)

31 (27.9%)

0.999

Median time to CLAD development, months (IQR)

60 (24–60)

24 (12–45)

72 (36–96)

0.036

Pseudomonas colonization, n (%)

29 (23.4%)

8 (61.5%)

21 (18.9%)

0.002

Median time to first isolation of Pseudomonas, months (IQR)

24 (6–78)

30 (4–93)

24 (9–66)

0.857

  1. LTX, lung transplant; IQR, interquartile range